113 related articles for article (PubMed ID: 14525769)
1. The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2.
Casoli C; De Lerma Barbaro A; Pilotti E; Bertazzoni U; Tosi G; Accolla RS
Blood; 2004 Feb; 103(3):995-1001. PubMed ID: 14525769
[TBL] [Abstract][Full Text] [Related]
2. The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.
Forlani G; Abdallah R; Accolla RS; Tosi G
J Virol; 2016 Jan; 90(7):3708-21. PubMed ID: 26792751
[TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication.
Tosi G; Forlani G; Andresen V; Turci M; Bertazzoni U; Franchini G; Poli G; Accolla RS
J Virol; 2011 Oct; 85(20):10719-29. PubMed ID: 21813598
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication.
Orlandi C; Forlani G; Tosi G; Accolla RS
J Transl Med; 2011 Jul; 9():106. PubMed ID: 21736733
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.
Tosi G; Pilotti E; Mortara L; De Lerma Barbaro A; Casoli C; Accolla RS
Proc Natl Acad Sci U S A; 2006 Aug; 103(34):12861-6. PubMed ID: 16908858
[TBL] [Abstract][Full Text] [Related]
6. The tax protein from the primate T-cell lymphotropic virus type 3 is expressed in vivo and is functionally related to HTLV-1 Tax rather than HTLV-2 Tax.
Chevalier SA; Meertens L; Pise-Masison C; Calattini S; Park H; Alhaj AA; Zhou M; Gessain A; Kashanchi F; Brady JN; Mahieux R
Oncogene; 2006 Jul; 25(32):4470-82. PubMed ID: 16532031
[TBL] [Abstract][Full Text] [Related]
7. The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators.
Forlani G; Abdallah R; Accolla RS; Tosi G
Front Microbiol; 2013; 4():234. PubMed ID: 23986750
[TBL] [Abstract][Full Text] [Related]
8. The dual function of the MHC class II transactivator CIITA against HTLV retroviruses.
Tosi G; Bozzo L; Accolla RS
Front Biosci (Landmark Ed); 2009 Jan; 14(11):4149-56. PubMed ID: 19273341
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional activation of the intercellular adhesion molecule 1 (CD54) gene by human T lymphotropic virus types I and II Tax is mediated through a palindromic response element.
Owen SM; Rudolph DL; Dezzutti CS; Shibata N; Naik S; Caughman SW; Lal RB
AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1429-37. PubMed ID: 9359663
[TBL] [Abstract][Full Text] [Related]
10. Isolation, cloning, and complete nucleotide sequence of a phenotypically distinct Brazilian isolate of human T-lymphotropic virus type II (HTLV-II).
Lewis MJ; Novoa P; Ishak R; Ishak M; Salemi M; Vandamme AM; Kaplan MH; Hall WW
Virology; 2000 May; 271(1):142-54. PubMed ID: 10814579
[TBL] [Abstract][Full Text] [Related]
11. Comparison of CREB- and NF-kappaB-mediated transactivation by human T lymphotropic virus type II (HTLV-II) and type I (HTLV-I) tax proteins.
Lewis MJ; Sheehy N; Salemi M; VanDamme AM; Hall WW
Virology; 2002 Mar; 295(1):182-9. PubMed ID: 12033776
[TBL] [Abstract][Full Text] [Related]
12. Human T-cell leukemia virus type 2 tax mutants that selectively abrogate NFkappaB or CREB/ATF activation fail to transform primary human T cells.
Ross TM; Narayan M; Fang ZY; Minella AC; Green PL
J Virol; 2000 Mar; 74(6):2655-62. PubMed ID: 10684280
[TBL] [Abstract][Full Text] [Related]
13. Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo.
Yamamoto B; Li M; Kesic M; Younis I; Lairmore MD; Green PL
Retrovirology; 2008 May; 5():38. PubMed ID: 18474092
[TBL] [Abstract][Full Text] [Related]
14. Cell-type-specific transactivation of the parathyroid hormone-related protein gene promoter by the human T-cell leukemia virus type I (HTLV-I) tax and HTLV-II tax proteins.
Ejima E; Rosenblatt JD; Massari M; Quan E; Stephens D; Rosen CA; Prager D
Blood; 1993 Feb; 81(4):1017-24. PubMed ID: 8427983
[TBL] [Abstract][Full Text] [Related]
15. Human T-Cell Lymphotropic Virus Type 1 Transactivator Tax Exploits the XPB Subunit of TFIIH during Viral Transcription.
Martella C; Tollenaere AI; Waast L; Lacombe B; Groussaud D; Margottin-Goguet F; Ramirez BC; Pique C
J Virol; 2020 Mar; 94(8):. PubMed ID: 32024775
[TBL] [Abstract][Full Text] [Related]
16. Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat.
Lu H; Pise-Masison CA; Linton R; Park HU; Schiltz RL; Sartorelli V; Brady JN
J Virol; 2004 Jul; 78(13):6735-43. PubMed ID: 15194748
[TBL] [Abstract][Full Text] [Related]
17. Chromatin structure of recombinant Moloney murine leukemia virus proviral DNAs that contain tax-responsive sequences from human T-cell lymphotropic virus type II in the presence and absence of tax.
Kitado H; Fan H
J Virol; 1989 Jul; 63(7):3072-9. PubMed ID: 2786092
[TBL] [Abstract][Full Text] [Related]
18. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.
Alasiri A; Abboud Guerr J; Hall WW; Sheehy N
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142665
[TBL] [Abstract][Full Text] [Related]
19. HTLV-I and HTLV-II Tax: differences in induction of micronuclei in cells and transcriptional activation of viral LTRs.
Semmes OJ; Majone F; Cantemir C; Turchetto L; Hjelle B; Jeang KT
Virology; 1996 Mar; 217(1):373-9. PubMed ID: 8599225
[TBL] [Abstract][Full Text] [Related]
20. Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator.
Younis I; Khair L; Dundr M; Lairmore MD; Franchini G; Green PL
J Virol; 2004 Oct; 78(20):11077-83. PubMed ID: 15452228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
